Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-19), Vaxxa AB's 9-Day RSI is 58.14.
The industry rank for Vaxxa AB's 9-Day RSI or its related term are showing as below:
FRA:7WA0's 9-Day RSI is ranked worse than 83.77% of 2932
companies
in the Software industry
Industry Median: 45.395
vs FRA:7WA0: 58.14
Vaxxa AB (FRA:7WA0) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Vaxxa AB 9-Day RSI Related Terms
FRA:7WA0 vs UBER, SHOP, CRM: 9-Day RSI Comparison
For the Software - Application subindustry, Vaxxa AB's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxxa AB 9-Day RSI vs Software Industry
For the Software industry and Technology sector, Vaxxa AB's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Vaxxa AB's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxxa AB (FRA:7WA0) has a 9-Day RSI of 58.14 as of Jul. 19, 2026. According to the industry distribution chart, Vaxxa AB ranks #2456 out of 2932 companies in the Software industry, placing it in the top 83.8%.
Is Vaxxa AB's 9-Day RSI too high?
Vaxxa AB's current 9-Day RSI is 58.14. The Software industry median 9-Day RSI is 45.40. Vaxxa AB's value of 58.14 is 28.1% above this industry median. Based on the distribution chart, Vaxxa AB ranks #2456 out of 2932 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Vaxxa AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's 9-Day RSI compare to UBER and SHOP?
According to the Software industry distribution chart, Vaxxa AB ranks #2456 out of 2932 companies for 9-Day RSI. This places Vaxxa AB in the lower half of its industry. The industry median 9-Day RSI is 45.40. Vaxxa AB's value of 58.14 is 28.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Software company?
The median 9-Day RSI among Software companies is 45.40, based on 2,932 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaxxa AB's current 9-Day RSI of 58.14 is 28.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median 9-Day RSI is 45.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current 9-Day RSI is 58.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current 9-Day RSI of 58.14. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 33.2% below its estimated fair value. The current 9-Day RSI is 58.14 and 28.1% above the Software industry median of 45.40. Vaxxa AB's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current 9-Day RSI is 58.14 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?
Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued.
The current stock price of €0.03 is trading 33.2% below its estimated GF Value™ of €0.05.
Key valuation signals for FRA:7WA0:
9-Day RSI: 58.14
GF Value™: €0.05 vs. price of €0.03 (33.2% below fair value)
Industry Position: 28.1% above the Software median (#2456 of 2932)
No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
25GF Score
Get the complete analysis for FRA:7WA0
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7WA0 has been successfully added to your 
